The crosstalk between the cardiovascular and the immune system
Vascular Biology · 2019
DOI: 10.1530/vb-19-0023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vascular Biology, 2019. Verfasst von Carlo Dal Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac, Thoracic and Vascular Sciences, Padua University-Hospital, Padua, Italy. Die Arbeit wurde bisher 30-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The heart and the immune system are highly integrated systems cross-talking through cytokines, hormones and neurotransmitters. Their balance can be altered by numerous physical or psychological stressors leading to the onset of inflammation, endothelial dysfunction and tissue damage. Here, we review the main players and mechanisms involved in the field. A new research paradigm, which considers also novel contributors, like endothelial cells, is needed to better understand the pathophysiology of immune-mediated cardiovascular disorders and beyond.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac, Thoracic and Vascular Sciences, Padua University-Hospital, Padua, Italy.
- University and University Hospital Zurich, Institute of Clinical Chemistry, Zurich, Switzerland.
- University Hospital Zurich, Heart Center, Zurich, Switzerland.
- Swiss Federal Institute of Technology (ETH), Laboratory of Translational Nutrition Biology, Zurich, Switzerland.
Zitieren
APA
Dal Lin, C., Tona, F., & Osto, E. (2019). The crosstalk between the cardiovascular and the immune system. Vascular Biology. https://doi.org/10.1530/vb-19-0023
Vancouver
Dal Lin C, Tona F, Osto E. The crosstalk between the cardiovascular and the immune system. Vascular Biology. 2019. doi:10.1530/vb-19-0023
BibTeX
@article{DalLin2019,
author = {Dal Lin, Carlo and Tona, Francesco and Osto, Elena},
title = {The crosstalk between the cardiovascular and the immune system},
journal = {Vascular Biology},
year = {2019},
doi = {10.1530/vb-19-0023}
}
EUVIMED